{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:37:42Z","timestamp":1794958662056,"version":"4.9.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.waojou.2020.100472","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T16:31:46Z","timestamp":1604075506000},"page":"100472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1065,"title":["World Allergy Organization Anaphylaxis Guidance 2020"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2197-9767","authenticated-orcid":false,"given":"Victoria","family":"Cardona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio J.","family":"Ansotegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Ebisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehia","family":"El-Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Fernandez Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Fineman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Gonzalez-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sanchez Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianenrico","family":"Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Kase","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard Y.","family":"Thong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100472_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of allergy and clinical immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1398-9995.2007.01433.x","article-title":"Evidence-based management of anaphylaxis","volume":"62","author":"Simons","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib4","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12418","article-title":"Epidemiology of anaphylaxis","volume":"45","author":"Tejedor Alonso","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0234-0","article-title":"Critical view of anaphylaxis epidemiology\u00a0: open questions and new perspectives","volume":"14","author":"Tanno","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/all.13732","article-title":"The global incidence and prevalence of anaphylaxis in children in the general population: a systematic review","volume":"74","author":"Wang","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib7","first-page":"163","article-title":"Epidemiology of anaphylaxis: contributions from the last 10 years","volume":"25","author":"Tejedor-Alonso","year":"2015","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40521-016-0094-0","article-title":"Current trends in prevalence and mortality of anaphylaxis","volume":"3","author":"Ansotegui","year":"2016","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib9","series-title":"Global Trends in Anaphylaxis Epidemiology and Clinical Implications","author":"Turner","year":"2019"},{"key":"10.1016\/j.waojou.2020.100472_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: a systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2010.06.022","article-title":"The diagnosis and management of anaphylaxis practice parameter: 2010 update","volume":"126","author":"Lieberman","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/j.1326-5377.2006.tb00563.x","article-title":"Anaphylaxis: diagnosis and management","volume":"185","author":"Brown","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/j.waojou.2020.100472_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report - second national Institute of allergy and infectious disease\/food allergy and anaphylaxis network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.waojou.2020.100472_bib14","unstructured":"No Title. https:\/\/icd.who.int\/browse11\/l-m\/en#\/http:\/\/id.who.int\/icd\/entity\/1868068711."},{"key":"10.1016\/j.waojou.2020.100472_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40413-016-0115-2","article-title":"Dissemination of definitions and concepts of allergic and hypersensitivity conditions","volume":"9","author":"Tanno","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib16","unstructured":"ASCIA Anaphylaxis Clinical Update. https:\/\/www.allergy.org.au\/images\/stories\/hp\/info\/ASCIA_HP_Clinical_Update_Anaphylaxis_Dec2016.pdf (accessed 21 May2020)."},{"key":"10.1016\/j.waojou.2020.100472_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib18","series-title":"Fatal Anaphylaxis: Postmortem Findings and Associated Comorbid Diseases","author":"Greenberger","year":"2007"},{"key":"10.1016\/j.waojou.2020.100472_bib19","article-title":"Risk factors for fatal anaphylaxis","volume":"vols. 32\u201348","author":"Pumphrey","year":"2014"},{"key":"10.1016\/j.waojou.2020.100472_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/JAA.S159400","article-title":"Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities","volume":"11","author":"Prince","year":"2018","journal-title":"J\u00a0Asthma Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/all.12475","article-title":"First European data from the network of severe allergic reactions (NORA)","volume":"69","author":"Worm","year":"2014","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib22","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.jaip.2018.02.026","article-title":"Epinephrine in severe allergic reactions: the European anaphylaxis register","volume":"6","author":"Grabenhenrich","year":"2018","journal-title":"J\u00a0allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib23","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/cea.12211","article-title":"Incidence of fatal food anaphylaxis in people with food allergy: a systematic review and meta-analysis","volume":"43","author":"Umasunthar","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/all.12924","article-title":"Can we identify patients at risk of life-threatening allergic reactions to food?","author":"Turner","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib26","doi-asserted-by":"crossref","first-page":"100066","DOI":"10.1016\/j.waojou.2019.100066","article-title":"Time to revisit the definition and clinical criteria for anaphylaxis?","volume":"12","author":"Turner","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cea.13117","article-title":"Important and specific role for basophils in acute allergic reactions","volume":"48","author":"Koro\u0161ec","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.03.031","article-title":"Investigation into the \u03b1-gal syndrome: characteristics of 261 children and adults reporting red meat allergy","author":"Wilson","year":"2019","journal-title":"J Allergy Clin Immunol Pract Published Online First:"},{"key":"10.1016\/j.waojou.2020.100472_bib29","series-title":"Acute Management of Anaphylaxis","year":"2017"},{"key":"10.1016\/j.waojou.2020.100472_bib30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/archdischild-2018-314867","article-title":"Myths, facts and controversies in the diagnosis and management of anaphylaxis","volume":"104","author":"Anagnostou","year":"2019","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.waojou.2020.100472_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100472_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40521-015-0053-1","article-title":"Definition, epidemiology, and pathogenesis","volume":"2","author":"Sala-Cunill","year":"2015","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACI.0b013e3283036a90","article-title":"Understanding the mechanisms of anaphylaxis","volume":"8","author":"Peavy","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2010.02422.x","article-title":"Anaphylaxis: past, present and future","volume":"66","author":"Ben-Shoshan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib35","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaci.2008.11.004","article-title":"Peanuts can contribute to anaphylactic shock by activating complement","volume":"123","author":"Khodoun","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib36","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1016\/j.jaci.2007.08.061","article-title":"9. Anaphylaxis","volume":"121","author":"Simons","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib37","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1056\/NEJMoa0806450","article-title":"Outbreak of adverse reactions associated with contaminated heparin","volume":"359","author":"Blossom","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100472_bib38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2014.07.057","article-title":"Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions","volume":"135","author":"Sala-Cunill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib39","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.1105695108","article-title":"Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis","volume":"108","author":"Khodoun","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.waojou.2020.100472_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.03.044","article-title":"Distinct immune effector pathways contribute to the full expression of peanut-induced anaphylactic reactions in mice","volume":"127","author":"Arias","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0091-6749(93)90266-I","article-title":"Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables","volume":"91","author":"MacGlashan","year":"1993","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib42","series-title":"Histamine-releasing and Allergenic Properties of Opioid Analgesic Drugs: Resolving the Two. in: Anaesthesia and Intensive Care","first-page":"216","author":"Baldo","year":"2012"},{"key":"10.1016\/j.waojou.2020.100472_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.waojou.2020.100472_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.18176\/jiaci.0046","article-title":"Mechanisms of anaphylaxis beyond IgE","volume":"26","author":"Mu\u00f1oz-Cano","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/cea.13402","article-title":"Idiopathic anaphylaxis","volume":"49","author":"Bil\u00f2","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2014.06.031","article-title":"Recognizing mastocytosis in patients with anaphylaxis: value of KIT D816V mutation analysis of peripheral blood","volume":"135","author":"Broesby-Olsen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jaip.2019.01.006","article-title":"Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome","volume":"7","author":"Valent","year":"2019","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.waojou.2020.100472_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaip.2019.09.017","article-title":"Diagnosis and management of patients with the \u03b1-gal syndrome","volume":"8","author":"Platts-Mills","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ACI.0000000000000625","article-title":"Molecular diagnosis usefulness for idiopathic anaphylaxis","volume":"20","author":"Cardona","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib50","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3904\/kjim.2018.094","article-title":"Prevalence of anaphylaxis and prescription rates of epinephrine auto-injectors in urban and rural areas of Korea","volume":"34","author":"Cho","year":"2019","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.waojou.2020.100472_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13098","article-title":"Anaphylaxis - lessons learnt when East meets West","author":"Tham","year":"2019","journal-title":"Pediatr Allergy Immunol Published Online First"},{"key":"10.1016\/j.waojou.2020.100472_bib52","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.3346\/jkms.2019.34.e106","article-title":"Infantile anaphylaxis in Korea: a multicenter retrospective case study","volume":"34","author":"Jeon","year":"2019","journal-title":"J\u00a0Kor Med Sci"},{"key":"10.1016\/j.waojou.2020.100472_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5415\/apallergy.2013.3.1.29","article-title":"Paediatric anaphylaxis in a Singaporean children cohort: changing food allergy triggers over time","volume":"3","author":"Liew","year":"2013","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib55","first-page":"480","article-title":"Characteristics, etiology and treatment of pediatric and adult anaphylaxis in Iran","volume":"16","author":"Nabavi","year":"2017","journal-title":"Iran J Allergy, Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib56","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40413-018-0200-9","article-title":"Anaphylaxis triggers in a large tertiary care hospital in Qatar: a retrospective study","volume":"11","author":"Abunada","year":"2018","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5415\/apallergy.2013.3.1.29","article-title":"Paediatric anaphylaxis in a Singaporean children cohort: changing food allergy triggers over time","volume":"3","author":"Liew","year":"2013","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib58","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2015.11.015","article-title":"Anaphylaxis in children and adolescents: the European anaphylaxis registry","volume":"137","author":"Grabenhenrich","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib59","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/cea.12011","article-title":"Lipid transfer proteins: the most frequent sensitizer in Italian subjects with food-dependent exercise-induced anaphylaxis","volume":"42","author":"Romano","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000375469","article-title":"Fruit and vegetable allergy","volume":"101","author":"Fern\u00e1ndez-Rivas","year":"2015","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib61","series-title":"Food Allergy in Lebanon: Is Sesame Seed the \u2018Middle Eastern\u2019 Peanut","author":"Irani","year":"2011"},{"key":"10.1016\/j.waojou.2020.100472_bib62","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4168\/aair.2017.9.5.423","article-title":"Age- based causes and clinical characteristics of immediate-type food allergy in Korean children","volume":"9","author":"Jeong","year":"2017","journal-title":"Allergy, Asthma Immunol Res"},{"key":"10.1016\/j.waojou.2020.100472_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0000000000000175","article-title":"Hidden allergens and oral mite anaphylaxis: the pancake syndrome revisited","volume":"15","author":"S\u00e1nchez-Borges","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib64","unstructured":"Kruse B, Simon L V. Bites, Fire Ant. StatPearls Publishing http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29261949 (accessed 28 Jun2020)."},{"key":"10.1016\/j.waojou.2020.100472_bib65","first-page":"17","article-title":"Venomous bites, stings, and poisoning","volume":"33","author":"Warrell","year":"2019","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.waojou.2020.100472_bib66","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib67","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMc1810168","article-title":"Olaparib desensitization in a patient with recurrent peritoneal cancer","volume":"379","author":"Grabowski","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100472_bib68","first-page":"68","article-title":"Chlorhexidine-induced anaphylaxis occurring in the workplace in a health-care worker: case report and review of the literature","volume":"109","author":"Toletone","year":"2018","journal-title":"Med Lav"},{"key":"10.1016\/j.waojou.2020.100472_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13223-016-0172-7","article-title":"Polyethylene glycol as a cause of anaphylaxis","volume":"12","author":"Wylon","year":"2016","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib70","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1180","article-title":"Anaphylaxis to carboxymethylcellulose: add food additives to the list of elicitors","volume":"143","author":"Ohnishi","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.waojou.2020.100472_bib71","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.bja.2019.01.027","article-title":"Comparative epidemiology of suspected perioperative hypersensitivity reactions","volume":"123","author":"Mertes","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.waojou.2020.100472_bib72","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.intimp.2018.07.020","article-title":"Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2","volume":"62","author":"Che","year":"2018","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.waojou.2020.100472_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061223","article-title":"Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed Patho-Mechanism: IgE-Mediated, pharmacological adverse reaction or \u201cinnate hypersensitivity\u201d?","volume":"18","author":"Spoerl","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.waojou.2020.100472_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29965-8","article-title":"MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia","volume":"8","author":"Navin\u00e9s-Ferrer","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.waojou.2020.100472_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01193","article-title":"Mechanisms, cofactors, and augmenting factors involved in anaphylaxis","volume":"8","author":"Mu\u00f1oz-Cano","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib76","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1398-9995.2012.02877.x.","article-title":"Co-factor-enhanced food allergy","volume":"67","author":"Cardona","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib77","first-page":"153","volume":"37","author":"Schuch","year":"2017","journal-title":"Mastocytosis and Anaphylaxis. Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.waojou.2020.100472_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1573396314666180507115115","article-title":"Anaphylaxis in children: epidemiology, risk factors and management","volume":"14","author":"Anagnostou","year":"2018","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.waojou.2020.100472_bib79","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from the European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib80","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2019.06.038","article-title":"Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: a randomized controlled study","volume":"144","author":"Dua","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib81","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/all.12193","article-title":"About the role and underlying mechanisms of cofactors in anaphylaxis","volume":"68","author":"W\u00f6lbing","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib83","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaip.2018.10.042","article-title":"Relationship between anaphylaxis and use of beta-blockers and angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis of observational studies","volume":"7","author":"Tejedor-Alonso","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib84","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of allergy and clinical immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib85","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis\u2014a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib86","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis\u2014a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib87","doi-asserted-by":"crossref","DOI":"10.1159\/000477566","article-title":"Safety of adrenaline use in anaphylaxis: a multicentre register","author":"Cardona","year":"2017","journal-title":"Int Arch Allergy Immunol Published Online First"},{"key":"10.1016\/j.waojou.2020.100472_bib88","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jaip.2014.06.007","article-title":"Epinephrine in anaphylaxis: higher risk of cardiovascular complications and overdose after administration of intravenous bolus epinephrine compared with intramuscular epinephrine","volume":"3","author":"Campbell","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/emj.2003.009449","article-title":"Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation","volume":"21","author":"Brown","year":"2004","journal-title":"Emerg Med J"},{"key":"10.1016\/j.waojou.2020.100472_bib90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1742-6723.2006.00831.x","article-title":"Anaphylaxis: clinical concepts and research priorities","volume":"18","author":"Brown","year":"2006","journal-title":"EMA - Emerg. Med. Australas."},{"key":"10.1016\/j.waojou.2020.100472_bib91","first-page":"1","article-title":"Acute management of anaphylaxis guidelines","year":"2019","journal-title":"Clin Pract Guidel Portal"},{"key":"10.1016\/j.waojou.2020.100472_bib92","series-title":"Gu\u00eda de actuaci\u00f3n en ANAFILAXIA: GALAXIA","author":"Cardona","year":"2016"},{"key":"10.1016\/j.waojou.2020.100472_bib93","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40413-015-0080-1","article-title":"Update of the evidence base: world Allergy Organization anaphylaxis guidelines","volume":"8","author":"Simons","year":"2015","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib94","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.jaip.2019.04.018","article-title":"Evaluation of prehospital management in a Canadian emergency department anaphylaxis cohort","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/1742-6723.12028","article-title":"Parenteral antihistamines cause hypotension in anaphylaxis","volume":"25","author":"Ellis","year":"2013","journal-title":"EMA - Emerg Med Australas"},{"key":"10.1016\/j.waojou.2020.100472_bib96","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.jaip.2019.07.005","article-title":"Anaphylaxis management: time to Re-evaluate the role of corticosteroids","volume":"7","author":"Campbell","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib97","doi-asserted-by":"crossref","first-page":"196","DOI":"10.23822\/EurAnnACI.1764-1489.15","article-title":"Corticosteroids in management of anaphylaxis; a systematic review of evidence","volume":"49","author":"Liyanage","year":"2017","journal-title":"Eur. Ann. Allergy Clin. Immunol."},{"key":"10.1016\/j.waojou.2020.100472_bib98","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ajem.2018.05.009","article-title":"Biphasic anaphylaxis: a review of the literature and implications for emergency management","volume":"36","author":"Pourmand","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.waojou.2020.100472_bib99","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaip.2017.05.022","article-title":"Do corticosteroids prevent biphasic anaphylaxis?","volume":"5","author":"Alqurashi","year":"2017","journal-title":"J\u00a0allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib100","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.anai.2015.07.015","article-title":"Biphasic reactions in patients with anaphylaxis treated with corticosteroids","volume":"115","author":"Ko","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib101","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/emj.2005.023507","article-title":"Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers","volume":"22","author":"Thomas","year":"2005","journal-title":"Emerg Med J"},{"key":"10.1016\/j.waojou.2020.100472_bib102","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaip.2014.12.010","article-title":"Time of onset and predictors of biphasic anaphylactic reactions: a systematic review and meta-analysis","volume":"3","author":"Lee","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib103","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354543","article-title":"World allergy organization anaphylaxis guidelines: 2013 update of the evidence base","volume":"162","author":"Simons","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/S1081-1206(10)60729-6","article-title":"SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department","volume":"98","author":"Lieberman","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-019-0324-7","article-title":"A\u00a0systematic review of epinephrine stability and sterility with storage in a syringe","volume":"15","author":"Parish","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib106","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/cea.13287","article-title":"Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies","volume":"48","author":"Pouessel","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib107","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jaci.2005.12.002","article-title":"Anaphylaxis, killer allergy: long-term management in the community","volume":"117","author":"Simons","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib108","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1365-2222.2003.01754.x","article-title":"Managing anaphylaxis: effective emergency and long-term care are necessary","volume":"33","author":"Walker","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-018-0215-x","article-title":"Assessing severity of anaphylaxis: a data-driven comparison of 23 instruments","volume":"8","author":"Eller","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaip.2016.11.009","article-title":"World allergy organization systemic allergic reaction grading system: is a modification needed?","volume":"5","author":"Cox","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib111","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib112","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib113","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/ACI.0000000000000184","article-title":"Biomarkers of anaphylaxis, beyond tryptase","volume":"15","author":"Sala-Cunill","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib114","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI mast cell disorders committee work group report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib116","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-020-08777-7","article-title":"Using baseline and peak serum tryptase levels to diagnose anaphylaxis: a review","author":"Passia","year":"2020","journal-title":"Clin Rev Allergy Immunol Published Online First"},{"key":"10.1016\/j.waojou.2020.100472_bib117","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2017.06.003","article-title":"The pathophysiology of anaphylaxis","volume":"140","author":"Reber","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib118","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/1744666X.2017.1334552","article-title":"Anaphylaxis: epidemiology, aetiology and relevance for the clinic","volume":"13","author":"Dhami","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1939-4551-7-9","article-title":"International consensus on (ICON) anaphylaxis","volume":"7","author":"Simons","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13601-017-0151-1","article-title":"Quality indicators for the acute and long-term management of anaphylaxis: a systematic review","volume":"7","author":"Dhami","year":"2017","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib121","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ACI.0b013e328355b7e4","article-title":"Update: world allergy organization guidelines for the assessment and management of anaphylaxis","volume":"12","author":"Simons","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib122","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jaip.2018.07.044","article-title":"Teenagers and those with severe reactions are more likely to use their epinephrine autoinjector in cases of anaphylaxis in Canada","volume":"7","author":"Gabrielli","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib123","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.anai.2018.05.001","article-title":"Epinephrine, auto-injectors, and anaphylaxis: challenges of dose, depth, and device","volume":"121","author":"Brown","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib124","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2500\/aap.2018.39.4171","article-title":"Human factors engineering validation study for a novel 0.1-mg epinephrine auto-injector","volume":"39","author":"Edwards","year":"2018","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.waojou.2020.100472_bib125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaip.2013.02.004","article-title":"Auvi-Q versus EpiPen: preferences of adults, caregivers, and children","volume":"1","author":"Camargo","year":"2013","journal-title":"J\u00a0allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100472_bib126","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1208\/s12249-015-0306-0","article-title":"Sublingual diffusion of epinephrine microcrystals from rapidly disintegrating tablets for the potential first-aid treatment of anaphylaxis: in\u00a0vitro and ex\u00a0vivo study","volume":"16","author":"Rawas-Qalaji","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.waojou.2020.100472_bib127","series-title":"Idiopathic anaphylaxis yardstick: practical recommendations for clinical practice","author":"Carter","year":"2019"},{"key":"10.1016\/j.waojou.2020.100472_bib128","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2019.07.037","article-title":"Detection of KIT D816V mutation in patients with severe anaphylaxis and normal basal tryptase\u2014first data from the Anaphylaxis Registry (NORA)","volume":"144","author":"D\u00f6lle-Bierke","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib129","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/all.12318","article-title":"Management of anaphylaxis: a systematic review","volume":"69","author":"Dhami","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib130","doi-asserted-by":"crossref","DOI":"10.1186\/s40413-017-0148-1","article-title":"In-flight allergic emergencies","volume":"10","author":"S\u00e1nchez-Borges","year":"2017","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib131","unstructured":"WHO Model Lists of Essential Medicines. https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/(accessed 25 Aug2019)."},{"key":"10.1016\/j.waojou.2020.100472_bib132","article-title":"Action plan to reach the global availability of adrenaline auto-injectors","volume":"29","author":"Kase Tanno","year":"2018","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib133","doi-asserted-by":"crossref","DOI":"10.1111\/cea.12973","article-title":"Applying prevention concepts to anaphylaxis: a call for worldwide availability of adrenaline auto-injectors","volume":"47","author":"Tanno","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100472_bib134","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1081-1206(10)61129-5","article-title":"Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis","volume":"94","author":"Simons","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.anai.2010.01.023","article-title":"World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings","volume":"104","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib136","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60512-1","article-title":"Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community","volume":"102","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib137","unstructured":"World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva 2019 https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/325771\/WHO-MVP-EMP-IAU-2019.06-eng.pdf?ua=1."},{"key":"10.1016\/j.waojou.2020.100472_bib138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40413-016-0122-3","article-title":"Risk and safety requirements for diagnostic and therapeutic procedures in allergology: world Allergy Organization Statement","volume":"9","author":"Kowalski","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100472_bib139","first-page":"55","article-title":"The rate of epinephrine administration associated with allergy skin testing in a suburban allergy\u00a0practice from 1997 to 2010","volume":"3","author":"Swender","year":"2013","journal-title":"Allergy Rhinol"},{"key":"10.1016\/j.waojou.2020.100472_bib140","first-page":"75","article-title":"Systemic reactions from skin testing: literature review","volume":"16","author":"Liccardi","year":"2006","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib141","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.anai.2016.11.003","article-title":"Perspectives on the international classification of diseases, 11th revision, developments in allergy clinical practice in the United States. Ann allergy","volume":"118","author":"Tanno","year":"2017","journal-title":"Asthma Immunol"},{"key":"10.1016\/j.waojou.2020.100472_bib142","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jaci.2019.05.013","article-title":"Changing the history of anaphylaxis mortality statistics through the world health organization's international classification of diseases-11","volume":"144","author":"Tanno","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:41Z","timestamp":1761849761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":142,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1939455120303756"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100472","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Allergy Organization Anaphylaxis Guidance 2020","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100472","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100472"}}